CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CVRx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.35+0.05 (+3.85%)
Close on Oct 19, 2026
- Market cap
- $35.80M
- P/E (TTM)
- –
- Dividend yield
- –
CVRx, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | $13.65M | $14.95M | $13.49M | $12.24M | $11.20M | $14.36M | $12.30M | $10.67M | $9.84M | $10.29M | $9.58M | – | – |
| Germany | – | – | – | – | – | – | $1.64M | $807.00K | $802.00K | $877.00K | $871.00K | $802.00K | – | – |
| Other countries | – | – | – | – | $1.35M | $1.15M | $9.00K | $266.00K | $1.13M | $935.00K | $141.00K | $130.00K | – | – |
| Other countries | – | $1.12M | – | $1.20M | – | $1.15M | – | $1.07M | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of CVRx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.